HemaXis: Swiss blood testing company gets $2.5M for novel at-home system

DBS System, a Swiss company that makes a line of portable blood tests called HemaXis, has raised $2.5 million led by investiere. The funding was in Swiss francs, but the values of the currencies are currently approximately equal. Investiere contributed $800,000, Swiss pension fund Nest put in $700,000, and $1 million came from existing shareholders and angel investors.